Chemotherapy Induced Peripheral Neuropathy Treatment Report

By www.reliablebusinessinsights.com

Report Details

Report Name

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Outlook 2023 Story

Pages

112

Price

$ 2900

Features

Chemotherapy Induced Peripheral Neuropathy Treatment Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Kineta Inc
Krenitsky Pharmaceuticals Inc
PeriphaGen
Apexian Pharma
WinSanTor